Volume 80, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We compared four enzyme-linked immunosorbent assays (ELISAs) with 172 serum samples from 28 patients with alveolar echinococcosis in different clinical stages according to the World Health Organization–PNM (P = parasitic mass in the liver, N = involvement of neighboring organs, M = metastasis) staging system. The sequential antibody responses against Em , Em10, and Em18 antigens, and a crude antigen extract were measured in cohorts with resected and unresected lesions. Antibody levels in all assays correlated with the PNM stage before treatment, and the highest correlation was shown for the Em18 assay. The PNM stage did not influence the antibody kinetics, but changes in antibody levels depended on the treatment. In patients after curative surgery, seroreversion in the Em ELISA indicated successful resection of lesions in more patients than any other assay, irrespective of the clinical stage. There were no significant differences in the time before assays that use recombinant or purified antigens became unreactive. Antibodies directed against crude antigens were detectable longer than other antibodies in all patient cohorts and stages.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Ammann RW, Eckert J, 1996. Cestodes. Echinococcus. Gastroenterol Clin North Am 25 : 655–689. [Google Scholar]
  2. Reuter S, Buck A, Grebe O, Nussle-Kugele K, Kern P, Manfras BJ, 2003. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 47 : 3586–3591. [Google Scholar]
  3. Eckert J, Jacquier P, Baumann D, Raeber PA, 1995. Human echinococcosis in Switzerland, 1984–1992 [in German]. Schweiz Med Wochenschr 125 : 1989–1998. [Google Scholar]
  4. Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA, Gabelmann A, Kern P, Kratzer W, 2007. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast-enhanced ultrasound, three-phase helical CT and [(18)F]fluorodeoxyglucose positron-emission tomography. Abdom Imaging 32 : 730–736. [Google Scholar]
  5. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P, 1999. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 29 : 1157–1163. [Google Scholar]
  6. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, Deplazes P, von Schulthess GK, Muellhaupt B, Ammann RW, Renner EL, 2007. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 35 : 11–18. [Google Scholar]
  7. Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL; Swiss Echinococcosis Study Group, 2004. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976–2001). J Hepatol 41 : 551–559. [Google Scholar]
  8. Fujimoto Y, Ito A, Ishikawa Y, Inoue M, Suzuki Y, Ohhira M, Ohtake T, Kohgo Y, 2005. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis. J Gastroenterol 40 : 426–431. [Google Scholar]
  9. Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, Delabrousse E, Kratzer W, Bresson-Hadni S, 2006. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 55 : S283–S287. [Google Scholar]
  10. Frosch PM, Frosch M, Pfister T, Schaad V, Bitter-Suermann D, 1991. Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol 48 : 121–130. [Google Scholar]
  11. Sako Y, Nakao M, Nakaya K, Yamasaki H, Gottstein B, Lightowers MW, Schantz PM, Ito A, 2002. Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol 40 : 2760–2765. [Google Scholar]
  12. Wellinghausen N, Jochle W, Reuter S, Flegel WA, Grunert A, Kern P, 1999. Zinc status in patients with alveolar echinococcosis is related to disease progression. Parasite Immunol 21 : 237–241. [Google Scholar]
  13. Schantz PM, Wilson JF, Wahlquist SP, Boss LP, Rausch RL, 1983. Serologic tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multilocularis). Am J Trop Med Hyg 32 : 1381–1386. [Google Scholar]
  14. Wellinghausen N, Kern P, 2001. A new ImmunoCAP assay for detection of Echinococcus multilocularis-specific IgE. Acta Trop 79 : 123–127. [Google Scholar]
  15. Dreweck CM, Lüder CG, Soboslay PT, Kern P, 1997. Subclass-specific serological reactivity and IgG4-specific antigen recognition in human echinococcosis. Trop Med Int Health 2 : 779–787. [Google Scholar]
  16. Ito A, Schantz PM, Wilson JF, 1995. Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg 52 : 41–44. [Google Scholar]
  17. Ito A, Wen H, Craig PS, Liang M, Nakao M, Horii T, Pang XL, Okamoto M, Itho M, Osawa Y, Wang XG, Liu YH, 1997. Antibody responses against Em18 and Em16 serodiagnostic markers in alveolar and cystic echinococcosis. Jpn J Med Sci Biol 50 : 19–26. [Google Scholar]
  18. Wen H, Craig PS, Ito A, Vuitton DA, Bresson-Hadni S, Allan JC, Rogan M, Paollilo E, Shambesh M, 1995. Immunoblot evaluation of IgG and IgG subclass antibody responses for immunodiagnosis of human alveolar echinococcosis. Ann Trop Med Parasitol 89 : 485–495. [Google Scholar]
  19. Gottstein B, Tschudi K, Eckert J, Ammann R, 1989. Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans R Soc Trop Med Hyg 83 : 389–393. [Google Scholar]
  20. Gottstein B, Mesarina B, Tanner I, Ammann RW, Wilson JF, Eckert J, Lanier A, 1991. Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg 45 : 734–742. [Google Scholar]
  21. Ma L, Ito A, Liu YH, Wang XG, Yao YQ, Yu DG, Chen YT, 1997. Alveolar echinococcosis: Em2 plus-ELISA and Em18-western blots for follow-up after treatment with albendazole. Trans R Soc Trop Med Hyg 91 : 476–478. [Google Scholar]
  22. Miguet JP, Bresson-Hadni S, 1989. Alveolar echinococcosis of the liver. J Hepatol 8 : 373–379. [Google Scholar]
  23. Sturm D, Menzel J, Gottstein B, Kern P, 1995. Interleukin-5 is the predominant cytokine produced by peripheral blood mono-nuclear cells in alveolar echinococcosis. Infect Immun 63 : 1688–1697. [Google Scholar]
  24. Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B, 2003. In vitro culture of Echinococcus multilocularis and Echinococcus vogeli metacestodes: studies on the host-parasite interface. Acta Trop 85 : 145–155. [Google Scholar]
  25. Rausch RL, Wilson JF, Schantz PM, McMahon BJ, 1987. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 36 : 576–585. [Google Scholar]
  26. Posselt A, 1931. Die pathologische Anatomie der vielkammerigen Blasenwurmgeschwulst (Echinococcus alveolaris) der Leber. Frankf Z Pathol 41 : 45–99. [Google Scholar]
  27. Lanier AP, Trujillo DE, Schantz PM, Wilson JF, Gottstein B, McMahon BJ, 1987. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. Am J Trop Med Hyg 37 : 609–615. [Google Scholar]
  28. Gottstein B, 1992. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 5 : 248–261. [Google Scholar]

Data & Media loading...

  • Received : 02 Oct 2008
  • Accepted : 05 Jan 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error